Analytical Data
-
Gene name
FABP7
- Application
-
Alternative Names
FABP7；BLBP；FABPB;Fatty acid-binding Protein. brain
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O15540
-
Expression Region
2-132aa
-
AA Sequence
VEAFCATWK LTNSQNFDEY MKALGVGFAT RQVGNVTKPT VIISQEGDKV VIRTLSTFKN TEISFQLGEE FDETTADDRN CKSVVSLDGD KLVHIQKWDG KETNFVREIK DGKMVMTLTF GDVVAVRHYE KA
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fatty acid-binding protein 7 (FABP7), also known as brain-type FABP, is a member of the FABP family that plays a crucial role in the transport and metabolism of fatty acids within the brain. Emerging research highlights FABP7’s involvement in various neurological processes, including neuronal differentiation, survival, and neuroinflammation. It has been implicated in neurodevelopmental disorders and neurodegenerative diseases, making it a potential biomarker and therapeutic target. Given its significant role in brain function, recombinant FABP7 protein is increasingly used in experimental studies to understand its mechanisms of action, interactions with lipids, and effects on cellular processes. Producing and characterizing this recombinant protein enables researchers to investigate its structural properties, binding affinities, and regulatory pathways. Insights gained from such studies could pave the way for novel interventions in brain disorders, further emphasizing the importance of FABP7 in both basic neurobiology and clinical research. Understanding FABP7 could also contribute to developing therapeutic strategies targeting metabolic dysregulation in the brain, ultimately enhancing our grasp of brain health and disease.
